<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">17875526</PMID>
        <DateCompleted>
            <Year>2007</Year>
            <Month>11</Month>
            <Day>30</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0925-5710</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>86</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2007</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of hematology</Title>
                <ISOAbbreviation>Int. J. Hematol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more &quot;erythremic&quot; and less &quot;thrombocythemic&quot;: a molecular, histologic, and clinical study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>130-6</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>We investigated the prevalence of the JAK2 V617F gain-of-function mutation in patients with Philadelphia chromosome-negative chronic myeloproliferative disorders (Ph- MPD) and explored the links between JAK2 mutational status and the clinicopathologic picture of essential thrombocythemia (ET), chronic idiopathic myelofibrosis (CIMF), and polycythemia vera (PV). Allele-specific polymerase chain reaction results for 59 ET, 18 CIMF, and 9 PV cases were compared with values for clinical variables at presentation and last follow-up and with the diagnostic trephine bone marrow biopsy pictures. JAK2 V617F was found in 38 (64%) of ET cases, 7 (39%) of CIMF cases, and 9 (100%) of PV cases. The ET patients with the mutant JAK2 showed significantly higher (although not overtly polycythemic) red blood cell parameter values, lower platelet counts, and higher white blood cell counts. Similar trends were found in CIMF. Megakaryocyte clustering was much less pronounced in the CIMF cases with mutant JAK2, with an analogous trend occurring in the ET cases. Bone marrow cellularity values and the numbers of CD34+ and CD117+ blasts in the ET and CIMF groups did not differ. Fibrosis was slightly less marked in the ET cases with mutant JAK2. The mutation did not significantly influence the clinical course during the follow-up in either disease in the short term (median follow-up, 22 months). The JAK2 V617F mutation is prevalent in all Ph- MPD and may skew their presenting phenotype, including bone marrow histology, toward a more &quot;erythremic&quot; and less &quot;thrombocythemic&quot; phenotype.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rudzki</LastName>
                    <ForeName>Zbigniew</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathomorphology, Collegium Medicum, Jagiellonian University, Kraków, Poland. rudzki@heartofengland.nhs.uk</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sacha</LastName>
                    <ForeName>Tomasz</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stój</LastName>
                    <ForeName>Anastazja</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Czekalska</LastName>
                    <ForeName>Sylwia</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wójcik</LastName>
                    <ForeName>Małgorzata</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Skotnicki</LastName>
                    <ForeName>Aleksander B</ForeName>
                    <Initials>AB</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grabowska</LastName>
                    <ForeName>Barbara</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zduńczyk</LastName>
                    <ForeName>Andrzej</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Okoń</LastName>
                    <ForeName>Krzysztof</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stachura</LastName>
                    <ForeName>Jerzy</ForeName>
                    <Initials>J</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Japan</Country>
            <MedlineTA>Int J Hematol</MedlineTA>
            <NlmUniqueID>9111627</NlmUniqueID>
            <ISSNLinking>0925-5710</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>EC 2.7.10.2</RegistryNumber>
                <NameOfSubstance UI="D053614">Janus Kinase 2</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001853" MajorTopicYN="N">Bone Marrow</DescriptorName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001856" MajorTopicYN="N">Bone Marrow Examination</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D053614" MajorTopicYN="N">Janus Kinase 2</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009196" MajorTopicYN="N">Myeloproliferative Disorders</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011087" MajorTopicYN="N">Polycythemia Vera</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055728" MajorTopicYN="N">Primary Myelofibrosis</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013920" MajorTopicYN="N">Thrombocythemia, Essential</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2007</Year>
                <Month>9</Month>
                <Day>19</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2007</Year>
                <Month>12</Month>
                <Day>6</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2007</Year>
                <Month>9</Month>
                <Day>19</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">17875526</ArticleId>
            <ArticleId IdType="pii">9K44241260L65828</ArticleId>
            <ArticleId IdType="doi">10.1532/IJH97.E0607</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Blood. 2005 Sep 15;106(6):2162-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15920007</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2005 Nov 15;106(10):3370-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16037387</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Biol Cell. 2003 Apr;14(4):1448-59</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12686600</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 1999 Jan 15;93(2):417-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9885203</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Hematol. 2002 Aug;76(2):133-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12215011</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Cell. 2005 Apr;7(4):387-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15837627</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2005 Dec 3;366(9501):1945-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16325696</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Hematol. 1975 Oct;12 (4):409-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1105793</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 2006 Feb 1;106(3):631-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16369984</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Hematol. 1997 Jan;34(1):29-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9025160</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2005 Oct 15;106(8):2920-1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16204151</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mayo Clin Proc. 1998 Dec;73(12):1177-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9868417</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2003 Mar 27;348(13):1201-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12660384</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2006 Mar 1;107(5):2098-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16293597</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Haematol. 2006 Jan;132(2):244-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16398659</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mayo Clin Proc. 2004 Jul;79(7):953-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15244400</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Hematol. 2001 Mar;80(3):160-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11320901</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Haematol. 2005;114(1):7-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15995322</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Hematol. 2003 Mar;82(3):148-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12634946</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2005 Jun 17;280(24):22788-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15863514</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Leuk Lymphoma. 1996 Sep;22 Suppl 1:87-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8951778</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Haematol. 2005 Nov;131(3):320-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16225651</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Haematol. 2005 Oct;131(2):208-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16197451</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Hematol. 1975 Oct;12(4):339-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1198126</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1991 May 15;67(10):2658-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2015567</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Haematologica. 2000 May;85(5):492-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10800165</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2005 Apr 28;352(17):1779-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15858187</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Haematol. 2005 Sep;130(5):797-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16115143</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2005 Mar 19-25;365(9464):1054-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15781101</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Haematol. 2000 Aug;65(2):132-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10966175</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pol J Pathol. 2004;55(1):13-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15195702</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2005 Apr 28;434(7037):1144-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15793561</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 1998 May 1;93(3):385-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9590173</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Clin Pathol. 1971 Jul;56(1):24-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5556211</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2005 Aug 15;106(4):1207-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15860661</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mayo Clin Proc. 2005 Jul;80(7):947-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16007902</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>